Biocon annouces digital diabetes tie-up with Voluntis
Companies will develop and market several biosimilars
FDA finally gives cheaper copycat the thumbs-up
Mylan and Biocon resolve biosimilar manufacturing issues
Neulasta biosimilar hits trouble with regulators because of manufacturing issues
Regulators concerned over manufacturing standards.
FDA panel backs Herceptin and Avastin biosimilars.